Several teams abroad are working on the Dyskeratosis Congenita‘s association : Aplastic Anaemia they are very successful and they are linked with patients ‘ families.
Professor Dokal is in charge of these researches in Great Britain and Professors Bessler and Masson are doing them in USA......Read more...
On a therapeutic perspective, Doctor Thierry LEBLANC, in St Louis hospital in Paris is the person in charge of the research on aplastic anaemia and Dyskeratosis Congenita is part of it .......Read more...
On basic research , a team of researchers from the laboratory in Toulouse directed by Yves HENRY is working on components of the telomerase which have mutations in some forms of DC .....Read more...
Several studies, made by English-speaking researchers show Dyskeratosis Congenita as well as other hematologic disorders are mainly diseases characterized
by a genetic disorder due to mutations in genes which are essential for telomerase maintenance.
Fome of these researches are really efficient such as Professor Dokal ‘s research team, Professors Phil Masson and Monica Bessler in Washington University, and Blanche P Alter of National Cancer Institute, Bethesda (US).
With these researchers‘ studies, there can be new therapeutic treatments which can bring back a maintenance of telomeres with a gene therapy which target is the components of the telomerase .
